Publicaciones
-
Moreira DC, Hashmi SK, Andujar A, Berg F, Conger K, Fox Irwin L, Mikkelsen M, Antillón-Klussmann F, Bazzeh F, Cypriano M, Gao YJ, González-Ramella O, Rivas S, Lopes LF, Mack R, Morosini F, Noun D, Garcia X, Homsi MR, Puerto-Torres M, Agulnik A, Baker JN, Caniza MA, McNeil MJ, Qaddoumi I, Chantada G and Rodríguez-Galindo C.
The St. Jude Global Academy: A Multifaceted Education Program to Expand Pediatric Oncology Workforce Capacity.
PEDIATRIC BLOOD & CANCER . 72(3): .
-
Cristina Larrosa Espinosa, Simao-Rafael M, Salvador-Marcos N, Muñoz JP, Lavarino C, Chantada G and Mora J.
Case Report: Successful treatment of metastatic retinoblastoma with CNS involvement with anti-GD2 immunotherapy, intrathecal topotecan and reduced systemic chemotherapy
Frontiers in pediatrics . 12: 1509645-1509645.
-
Aschero MR, Simao M, Català-Mora J and Chantada G.
Risk Factors for Extraocular Relapse in Retinoblastoma
SEMINARS IN OPHTHALMOLOGY . : 1-11.
-
Esther Martínez García, López de San Roman Fernández C, Nishishinya Aquino MB, Pérez-Jaume S, Fernández-Jané C, Cruz-Martínez O and Morales-La Madrid A.
Patient Acceptability of the First Integrative Pediatric Oncology Unit in Spain-The Pediatric Cancer Center Barcelona Experience: A Retrospective Study
Cancers . 17(2): .
-
Cancela MB, Winter U, Zugbi S, Dinardi M, Alves da Quinta D, Aschero MR, Ganiewich D, Sampor C, Sgroi M, Lagomarsino E, Fandiño A, Llera AS, Chantada G, Carcaboso AM and Schaiquevich P.
Mimicking Retinoblastoma Treatment With Repeated Topotecan or Melphalan Develops Cross-Resistance to Classic Agents But Not to Repurposed Drugs
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE . 65(14): 14-14.
-
Sampor C, Alonso R, Durañona M, Gorostegui M, Antillón-Klussmann F, Lopes LF, Cappellano AM, Gonzalez-Ramella O, Lobos P, Palma J, Grynszpancholc E, Vasquez L, Morales-La Madrid A, Moreira DC, Cruz-Martínez O and Chantada G.
The TeLeo Program: Tele-education in pediatric oncology as a tool to support training programs in Latin America.
PEDIATRIC BLOOD & CANCER . 71(12): .
-
Tauziède-Espariat A, Friker LL, Nussbaumer G, Bison B, Dangouloff-Ros V, Métais A, Sumerauer D, Zamecnik J, Benesch M, Perwein T, van Vuurden D, Wesseling P, Morales-La Madrid A, Garrè ML, Antonelli M, Giangaspero F, Pietsch T, Sturm D, Jones DTW, Pfister SM, Grabovska Y, Mackay A, Jones C, Grill J, Ajlil Y, von Bueren AO, Karremann M, Hoffmann M, Kramm CM, Kwiecien R, Castel D, Gielen GH and Varlet P.
Diffuse pediatric high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features including Gliomatosis cerebri phenotype.
Acta neuropathologica communications . 12(1): 176-176.
-
Gorostegui-Obanos M, Chantada L, Filho NPC, Gonzalez-Ramella O, Serrano B MJ, Valencia D, Sampor C, Macedo C, Ramirez O, Sardinas S, Lezcano E, Calderón P, Gamboa Y, Fu L, Gómez W, Schelotto M, Ugaz C, Lobos P, Moreno K, Palma J, Sánchez G, Moschella F, Gassant PYH, Velasquez T, Quintero K, Forteza M, Villarroel M, Moreno F, Alabi SF, Vasquez L, Lowe J, Cappellano A, Challinor J and Chantada G.
International Society of Paediatric Oncology (SIOP) Global Mapping Program: Analysis of healthcare centers in countries of the Latin American Society of Pediatric Oncology (SLAOP).
PEDIATRIC BLOOD & CANCER . 71(11): . Nº de citas: 1
-
Huchede P, Meyer S, Berthelot C, Hamadou M, Bertrand-Chapel A, Rakotomalala A, Manceau L, Tomine J, Lespinasse N, Lewandowski P, Cordier-Bussat M, Broutier L, Dutour A, Rochet I, Blay JY, Degletagne C, Attignon V, Carcaboso AM, Le Grand M, Pasquier E, Vasiljevic A, Gilardi-Hebenstreit P, Meignan S, Leblond P, Ribes V, Cosset E and Castets M.
BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas
eLife . 12: .
-
Liu I, Alencastro Veiga Cruzeiro G, Bjerke L, Rogers RF, Grabovska Y, Beck A, Mackay A, Barron T, Hack OA, Quezada MA, Molinari V, Shaw ML, Perez-Somarriba M, Temelso S, Raynaud F, Ruddle R, Panditharatna E, Englinger B, Mire HM, Jiang L, Nascimento A, LaBelle J, Haase R, Rozowsky J, Neyazi S, Baumgartner AC, Castellani S, Hoffman SE, Cameron A, Morrow M, Nguyen QD, Pericoli G, Madlener S, Mayr L, Dorfer C, Geyeregger R, Rota C, Ricken G, Ligon KL, Alexandrescu S, Cartaxo RT, Lau B, Uphadhyaya S, Koschmann C, Braun E, Danan-Gotthold M, Hu L, Siletti K, Sundström E, Hodge R, Lein E, Agnihotri S, Eisenstat DD, Stapleton S, King A, Bleil C, Mastronuzzi A, Cole KA, Waanders AJ, Carcaboso AM, Schüller U, Hargrave D, Vinci M, Carceller F, Haberler C, Slavc I, Linnarsson S, Gojo J, Monje M, Jones C and Filbin MG.
Article GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant
Cancer Cell . 42(9): . Nº de citas: 5